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Abstract
Background: Hantaviruses of the family Bunyaviridae are emerging zoonotic pathogens which cause hemorrhagic
fever with renal syndrome (HFRS) in the Old World and hantavirus pulmonary syndrome (HPS) in the New World.
An immune-mediated pathogenesis is discussed for both syndromes. The aim of our study was to investigate
cytokine expression during the course of acute Puumala hantavirus infection.
Results: We retrospectively studied 64 patients hospitalised with acute Puumala hantavirus infection in 2010
during a hantavirus epidemic in Germany. Hantavirus infection was confirmed by positive anti-hantavirus IgG/IgM.
Cytokine expression of IL-2, IL-5, IL-6, IL-8, IL-10, IFN-g, TNF-a and TGF-b1 was analysed by ELISA during the early
and late phase of acute hantavirus infection (average 6 and 12 days after onset of symptoms, respectively). A
detailed description of the demographic and clinical presentation of severe hantavirus infection requiring
hospitalization during the 2010 hantavirus epidemic in Germany is given. Acute hantavirus infection was
characterized by significantly elevated levels of IL-2, IL-6, IL-8, TGF-b1 and TNF-a in both early and late phase
compared to healthy controls. From early to late phase of disease, IL-6, IL-10 and TNF-a significantly decreased
whereas TGF-b1 levels increased. Disease severity characterized by elevated creatinine and low platelet counts was
correlated with high pro-inflammatory IL-6 and TNF-a but low immunosuppressive TGF-b1 levels and vice versa .
Conclusion: High expression of cytokines activating T-lymphocytes, monocytes and macrophages in the early
phase of disease supports the hypothesis of an immune-mediated pathogenesis. In the late phase of disease,
immunosuppressive TGF-b1 level increase significantly. We suggest that delayed induction of a protective immune
mechanism to downregulate a massive early pro-inflammatory immune response might contribute to the
pathologies characteristic of human hantavirus infection.
Background
Hantaviruses of the family Bunyaviridae are emerging
zoonotic pathogens which cause two distinct syndromes
in humans: hemorrhagic fever with renal syndrome
(HFRS) and hantavirus pulmonary syndrome (HPS)
[1-3]. Immunopathogenesis of both syndromes is char-
acterized by increased vascular permeability resulting in
severe capillary leakage and hemorrhagic diathesis. It is
therefore suggested that these similar underlying patho-
genic mechanisms are at least partly immune-mediated.
Hantaviruses are transmitted via rodents which are
asymptomatically infected and spread the virus to
humans by aerosolized secretion such as urine and feces
[4]. Typical modes of exposure are occupational forest
work, cleaning activities in contaminated buildings and
outdoor activities in areas were bank voles are abundant.
In 2010, a hantavirus epidemic was observed in Ger-
many with more than 2000 notified cases of hantavirus
infections which is the highest number ever since man-
datory reporting started [5]. Southwest Germany is the
main endemic area within Germany for infection with
Puumala virus (PUUV) which causes a mild form of
HFRS, called nephropathia epidemica (NE). Although
NE is generally a mild disease with an incubation time
of usually 2-3 weeks, after initially influenza-like symp-
toms, acute renal failure with anuria or oliguria, protei-
nuria, hematuria and thrombocytopenia is typical is seen
[6-8]. Clinical severity of NE varies considerably, but
prognosis is good and mortality is low [1].
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pro-inflammatory cytokines in the immunopathogen-
esis of HFRS/HPS [9-11]. The efficient anti-hantaviral
cell-mediated immune response in patients is mainly
due to the generation of cytotoxic CD8+ T-lympho-
cytes early in the course of disease [12,13]. Important
target cells of hantavirus in humans are monocytes
and macrophages, which may also play an important
role in the systemic spread of hantavirus from the pri-
mary site of infection, as well as endothelial cells.
Endothelial cells, monocytes and macrophages as well
as platelets can be a rich source of cytokines/chemo-
kines during the infection with hantavirus and contri-
bute to the HFRS/HPS immunopathogenesis [9-12].
Although most data are from patients with HFRS/HPS,
immunohistochemical staining and gene polymorphism
studies showed an association of pro-inflammatory
cytokines and disease in PUUV infection with signifi-
cantly elevated serum levels of TNF-a,I L - 6 ,I L - 2a n d
IFN-g in blood and urine [2,14,15].
Two recent studies shed further light on the immuno-
pathogenesis of acute PUUV infection [13,16]. Recently,
Saksida et al reported increased levels of IL-10, INF-g
and TNF-a in both Dobrava (DOBV) and PUUV
infected patients in Slovenia [16]. The authors found a
significant correlation of IL-10 and TNF-a with a more
severe course of disease in DOBV while PUUV infected
patients did not show this correlation but showed higher
IL-12 levels. Exact data on the interval between onset of
disease and sampling time point could not be deter-
mined, however the authors state that no time-depen-
dence of cytokine expression was seen. Lindgren et al
evaluated in a longitudinal study T-cell response in early
and late phase of acute PUUV infection during an han-
tavirus epidemic highlighting the role of CD8+ T cells
in the early phase of acute hantavirus infection and
describe the induction of inhibitory components in the
late phase to limit pro-inflammatory immune response
(average day 6 and 10, respectively) [13].
It has been suggested that HFRS pathogenesis is likely
to be a complex multifactorial process that includes
contributions from immune responses, platelet dysfunc-
tion, dysregulation of endothelial cell barrier functions
and hosts’ genetic factors [16]. Hence, we proposed that
disparity of pro- and anti-inflammatory cytokines is
responsible in part for the pathology seen in human
hantavirus infection. In the present study, we aimed to
investigate longitudinally expression of cytokines in the
early and late phase during the course of acute infection
in a hantavirus epidemic in 2010. We want to analyze
timing and intensity of pro- and anti-inflammatory cyto-
kines seen over the course of the infection. In our study
we aimed to systematically analyze clinical and immuno-
logical characteristics in a cohort of 64 patients
hospitalized with severe acute hantavirus infection.
Furthermore, we analyzed cytokine expression during
the early and late acute phase in comparison to healthy
control subjects.
Results
Patient characteristics and clinical findings
The patient cohort analyzed in our study consisted of 64
patients (Table 1). 89.7% of patients were adults while
10.3% were children and adolescents. This cohort was
representative regarding age distribution and seasonality
compared to nationwide data (Figure 1). A similar sea-
sonal distribution was detected in our cohort and for
nationwide cases with a peak in June. Age distribution
showed a higher percentage of patients in the age group
15-19 years in our cohort compared to nationwide data
(14.1% vs. 4.2%, respectively) and the highest proportion
of patients in the age group 30-39 years compared to
the highest incidence in the age group 40-49 years
nationwide, respectively (Figure 1).
Mean time from onset of disease until admission was
5.8 days, mean hospitalization time was 6.7 days. The
most common symptoms reported on admission were
fever, lumbalgia, headache, nausea, vomiting and
abdominal pain (Table 2). All patients had impaired
renal function to some degree on admission with an
increase in retention parameters over the course of dis-
ease, two patients (both children/adolescents) required
intermittent hemodialysis.
Laboratory findings on admission were elevated creati-
nine values with a mean of 4.2 mg/dl, CRP of 57.1 mg/l,
W B Co f9 . 6 / n l ,A S To f4 3 . 6U / l ,A L To f3 9 . 9U / la n d
thrombocytopenia of 168/nl (Table 2). During the
course of disease, serum creatinine increased to a maxi-
mum mean value of 5.5 mg/dl and platelets decreased
to a minimum mean value of 143/nl. Urine examination
on admission showed proteinuria and hematuria in
92.2% and 75% of all patients, respectively. Pathological
findings in chest x-ray were found in 41. 9% and ultra-
sound findings such as ascites, splenomegaly, hepatome-
galy and kidney enlargement were found in 28.6%,
Table 1 Characteristics of 64 hantavirus-infected patients
included in the study.
Patients characteristics (n = 64)
male 67.2%
female 32.8%
adult 89.7%
children/adolescents (age < 18 years) 10.3%
mean age, years ± SD 38.6 ± 16.4
mean hospitalization time, days ± SD 6.7 ± 4.5
mean time until admission, days ± SD 5.8 ± 3.5
Sex, age, hospitalization time and mean time until admission to hospital are
given.
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several unusual findings were observed in single patients
which are not frequently associated with hantavirus
infection (Table 3). On admission, the majority of
patients were seropositive for anti-PUUV IgG and/or
IgM antibodies (Figure 2). However three patients
(4.7%) presented without any detectable anti-PUUV
antibodies on admission but seroconversion could be
demonstrated in follow-up samples.
Cytokine levels in patients with acute hantavirus infection
versus healthy controls
The early phase of acute hantavirus infection (average 6
days after onset of symptoms) was characterized by sig-
nificant elevation of cytokine expression of IL-2, IL-6,
IL-8, TGF-b1 and TNF-a versus healthy controls (Table
4 and Figure 3). As patients showed strongly impaired
kidney function during the early phase of acute disease
and cytokines can accumulate in the blood because of
impaired renal excretion, additionally cytokine/creati-
nine ratios were analyzed which corresponded in their
significance fully with the blank cytokine expression.
Significantly elevated serum levels of IL-2, IL-6, IL-8,
TGF-b1a n dT N F - a were also observed when the late
phase of acute disease was compared with healthy con-
trols, demonstrating a profound and prolonged pro-
inflammatory response to hantavirus infection. No sig-
nificant difference was seen for IFN-g, IL-10 and IL-5 or
their respective cytokine/creatinine ratio compared to
healthy controls (Table 4).
Cytokine levels in early versus late phase of acute
hantavirus infection
To further analyze the relation of pro- and anti-inflam-
matory cytokines during the course of disease in acute
hantavirus infection, we compared expression of IL-2,
Figure 1 Comparison of seasonality (A) and age distribution (B) of hantavirus cases in Germany and our study cohort. Data source on
nationwide patient data: Robert Koch Institute.
Table 2 Mean laboratory values on admission and minimum/maximum values during hospitalization of the study
group.
parameter value on admission ± SD range reference values
creatinine on admission, mg/dl 4.2 ± 2.5 1.0 - 11.7 0.1 - 1.3
max. creatinine, mg/dl 5.5 ± 2.7 1.1 - 11.9 0.1 - 1.3
platelets on admission,/nl 168 ± 99 38 - 531 150 - 440
min. platelets,/nl 143 ± 99 37 - 531 150 - 440
C-reactive protein on admission, mg/l 57.1 ± 34.3 9.6 - 147.8 < 5
max. C-reactive protein, mg/l 66.0 ± 37.1 10.5- 148.0 < 5
WBC on admission,/nl 9.6 ± 3.2 4.7 - 16.4 4 - 10
max. WBC,/nl 11.2 ± 3.1 4.7 - 19.9 4 - 10
AST on admission, U/l 43.6 ± 25.7 14.0 - 156.0 < 35
max. AST, U/l 80.9 ± 120.8 27.0 - 907.0 < 35
ALT on admission, U/l 39.9 ± 24.0 10.0 - 113.0 < 35
max. ALT, U/l 93.0 ± 105.7 10.0 - 745 < 35
Results for important clinical laboratory markers during hantavirus infection are described.
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Page 3 of 10IL-5, IL-6. IL-8, IL-10, IFN-g,T N F - a and TGF-b1i n
early versus late phase of acute hantavirus infection
(average 6 and 12 days after onset of symptoms, respec-
tively) (Table 4 and Figure 4). A significant decrease
from early to late phase was seen for IL-6, IL-10 and
TNF-a while a significant increase in TGF-b1w a ss e e n .
No significant differences were seen for IL-2, IL-5, IL-8
and IFN-g although there was a trend for increase in IL-
2 (Table 4). Rapid decrease of the several main pro-
inflammatory mediators as well as increased TGF-b1
d u r i n gt h el a t ep h a s ei n d i c a te induction of inhibiting
mechanisms limiting early acute phase immune
response (Figure 4).
Correlation of cytokine expression with disease severity
Severity of disease defined by higher deviation from the
reference value of main blood parameters creatinine and
platelets was associated with high pro-inflammatory
cytokines and low TGF-b1 levels (Table 5). High serum
creatinine was associated with high IL-6, IL-8 and TNF-
a but low TGF-b1 levels. Low blood platelet counts
were associated with high IL-6, IL-10 and TNF-a and
low TGF-b1. In addition, time interval from beginning
of symptoms until measurement of cytokines was asso-
ciated with high TGF-b1. These findings suggest
increasing serum TGF-b1 and an association of high
TGF-b1 with improving kidney function and normaliz-
ing platelet counts in the late phase of disease. When
correlating TGF-b1 with pro-inflammatory cytokines,
TGF-b1 was associated with low IL-8, IL-10 and TNF-a
levels. Although high CRP was associated with high IL-
6, IL-8 and TNF-a, it did not correlate with TGF-b1.
Discussion
Southwest Germany is a main endemic area for PUUV
infection with a strong increase in hantavirus infections
in 2010 [5,17]. Most studies on PUUV so far have
described the clinical setting of NE in Western or
Northern Europe and the Balkans [4,7,18,19], but large
patient numbers have rarely been described from Ger-
many [20,21]. A recent study retrospectively describing
75 hantavirus infected patients over a 8-year period in
Southwest Germany found comparable clinical charac-
teristics, however, with average lower creatinine and
lower platelet numbers than observed in our study [21].
It should be noted, that lower creatinine values are not
expected to be associated with lower platelet numbers
in cases of hantavirus infection. Hospitalization time
was longer with average 9 days while our cohort had an
average mean hospitalization time of 7 days. Interest-
ingly, we observed a higher proportion of organ patholo-
gies of spleen, liver and lung with approx. 56%, 51% and
41% compared to 50%, 13% and 16%, respectively. We
want to highlight especially findings of pulmonary invol-
vement as there is evidence that the strict differentiation
regarding kidney and lung pathology in Old and New
World hantaviruses is not useful when studying patho-
genesis, further, pulmonary findings in Old Wold hanta-
virus infection are increasingly recognized [22-25]. In
contrast to nationwide data and other studies, we
observed a higher proportion of young patients aged 15-
19 years, however most studies are undertaken from
medical disciplines focusing on adult patients and access
t oal a r g ep e d i a t r i cu n i ti no u rs t u d ys i t em i g h tb i a s
these findings. We could further confirm the extreme
heterogeneity of NE mimicking a range of other diseases
especially in the initial phase of disease and found a
wide spectrum of unusual findings and complications in
Table 3 Symptoms and clinical findings of hantavirus-
infected patients.
Symptoms Frequency
fever 85.9%
lumbalgia 62.5%
headache 54.7%
nausea 45.6%
vomiting 39.1%
abdominal pain 35.9%
myalgia 28.1%
dizziness 25.0%
bradycardia 26.3%
vision disturbance 20.6%
diarrhea 20.3%
cough 21.9%
arthralgia 16.6%
collaps 10.9%
dyspnoea 12.5%
Clinical findings
proteinuria 59/64 (92.2%)
hematuria 48/64 (75.0%)
pathologic findings in chest x-ray 18/43 (41.9%)
ascites 10/35 (28.6%)
splenomegaly 24/43 (55.8%)
hepatomegaly 22/43 (51.2%)
kidney enlargement 35/61 (57.4%)
Unusual clinical findings associated with hantavirus infection
pulmonary edema
acute glaucoma attack
severe neurological involvement
exanthema
abortion
hepatitis
interstitial nephritis
seizure
hypertensive urgency
Liver vein congestion
The frequency of clinical symptoms and findings is shown to point out
common and uncommon symptoms. Additionally, unusual clinical findings are
depicted separately, these were found once in different patients, respectively.
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Page 4 of 10Figure 2 Detection of anti-Puumala virus antibodies (IgG, IgM) in hantavirus-infected patients on hospital admission. Three patients
presented without any detectable anti-PUUV antibodies on admission but seroconversion was detected in follow-up samples.
Table 4 Comparison of cytokines in early and late acute hantavirus infection and healthy controls.
parameter healthy controls
(n = 39)
early phase
(n = 64)
early phase*
(n = 21)
late phase
(n = 21)
p1 p2 p3
IL-2 (pg/ml),
IL-2/creatinine
2.2±8.6
2.7±12.2
9.5±7.2
3.8±4.5
7.2±5.6
3.2±3.9
14 ±17
15±25
<0.0001
<0.0001
<0.0001
<0.0001
0.08
0.005
IL-5 (pg/ml)
IL-5/creatinine
3.3±8.4
3.5±7.8
0.6±2.1
0.3±1.4
0.4±0.6
0.2±0.5
0.3±0.6
0.2±0.5
0.82
1.00
0.63
0.61
0.56
0.65
IL-6 (pg/ml)
IL-6/creatinine
1.1±1.6
1.3±2.0
7.8±9.8
2.5±3.1
8.2±6.1
3.3±3.6
2.6±2.4
1.8±1.2
<0.0001
0.0003
0.0002
0.004
0.001
0.17
IL-8 (pg/ml)
IL-8/creatinine
13±32
14±34
563±1809
161±406
444±1076
147±378
130±230
93±163
<0.0001
0.0001
0.001
0.002
0.16
0.57
IL-10 (pg/ml)
IL-10/creatinine
2.4±5.5
2.6±5.7
5.2±8.4
2.2±5.6
8.3±10.7
4.4±8.6
0.7±2.0
0.6±1.9
0.014
0.18
0.17
0.14
0.001
0.003
TNF-a (pg/ml) TNF-a/creatinine 0.8±1.0
0.9±1.1
5.2±4.2
1.7±1.4
6.4±4.6
2.2±1.9
3.6±3.1
3.0±2.9
<0.0001
0.001
<0.0001
<0.0001
0.001
0.09
TGF-b (pg/ml)
TGF-b/creatinine
4203±2132
4529±2266
23708±12207
11178±13749
21581±9068
8605±7184
32847±13513
29239±18032
<0.0001
0.004
<0.0001
<0.0001
0.004
0.0001
IFN-g (pg/ml)
IFN-g/creatinine
0.3±1.8
0.4±2.5
1.1±6.7
0.3±2.2
2.9±11.6
1.0±3.9
10.5±33.5
7.5±23.9
0.41
0.41
0.23
0.23
0.29
0.29
Statistical significant differences between healthy controls, patients with early hantavirus infection and patients with late hantavirus infection are shown in bold.
All data are given as mean±1SD. p1 = early phase acute hantavirus infection (n = 64) vs. healthy controls; p2 = late phase acute hantavirus infection vs. healthy
controls; p3 = early phase (n = 21) vs. late phase acute hantavirus infection. P-values were calculated using Mann-Whitney-U and Wilcoxon Signed-Rank tests.
Adjustment for multiple testing was done according to the method of Bonferroni. Only p-values of <0.01 after adjustment were considered to be significant and are
bold printed. *only early phase samples of patients for which a corresponding late phase sample was available. To exclude cytokine accumulation due to impairment
of renal excretion function, cytokine/creatinine ratios were calculated.
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Page 5 of 10Figure 3 Cytokine expression in patients (n = 64) with acute hantavirus infection during the early phase of disease (average 6 days
after onset of symptoms) versus healthy controls (n = 39). The line in the middle of each box represents the median. The lower and the
upper edges of the box are the 1st and 3rd quartile, respectively. There was a significant increase of IL-2, IL-6, IL-8, TGF-b1 and TNF-a during
early acute hantavirus infection versus healthy controls. To exclude accumulation of cytokines due to impairment of renal excretion function
during the early phase of acute disease, cytokine/creatinine ratios from the respective serum creatinine of every sample were calculated.
Significant boxplots (p < 0.05) are marked with *.
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the 2010 epidemic. Some of these findings might be
coincidental, however they are complicating diagnosis. It
is not clear if divergent clinical findings to other studies
such as higher number in organ pathology or higher
patient numbers in the young age group are hints for a
changing disease manifestation of hantavirus infection in
the 2010 epidemic or biased by analyzing a subgroup
with severe disease leading to hospitalization at a large
University hospital and intensive clinical monitoring. So
far, there are no other studies published on the 2010
hantavirus epidemic in Germany.
Diagnosis of hantavirus infection is confirmed by ser-
ological assays using the immunodominant nucleocap-
sid protein antigen [26-28]. By the time patients are
symptomatic, most patients develop IgM and IgG anti-
bodies [26,27,29]. Only few cases show delayed IgM
response, while the IgG response is delayed in 10% of
a c u t e - p h a s eI g M - p o s i t i v es e r a[ 3 0 , 3 1 ] .F o re a r l yt e s t i n g
or confirmation of questionable serological results,
viral RNA can be detected by RT-PCR, but is not rou-
tinely applied [30,32]. Although most patients in our
study group presented with positive anti-PUUV IgG
and IgM antibodies, a subset of patients were serone-
gative, had only borderline IgM or IgG antibodies on
admission but seroconverted during the course of dis-
ease. In contrast, in a recent report by Schilling et al.,
most patients presented with IgG and all patients pre-
sented with IgM antibodies during the acute phase in
a PUUV epidemic in 2004 in Southern Germany [30].
These findings highlight that antibody testing at multi-
p l et i m ep o i n t si sc o n c l u s i v ei ft h ec l i n i c a lp i c t u r ei s
suspicious for acute hantavirus infection. In case of
atypical presentation, molecular diagnostic methods
Figure 4 Cytokine expression during early (average 6 days after onset of symptoms) and late phase (average 12 days after onset of
symptoms) of acute hantavirus infection in 21 patients. The line in the middle of each box represents the median. The lower and the
upper edges of the box are the 1st and 3rd quartile, respectively. There was a significant decrease of IL-6, IL-10 and TNF-a and a significant
increase of TGF-b1. Significant boxplots (p < 0.05) are marked with *.
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Page 7 of 10such as PCR and sequencing of the infecting strain
should be considered [30,32].
Many studies have shown so far that cytokines play an
important role in the pathogenesis of human hantavirus
infection in both HFRS and HPS [14,33-36]. One of the
most investigated cytokine in acute hantavirus infection
of both syndromes HFRS and HPS is TNF-a which was
almost uniquely found overexpressed in acute hantavirus
infection [11,14,37]. TNF-a is produced by monocytes,
macrophages and T cells and is an inducer of NO
synthase with important effects on capillary endothelial
permeability.
Experimental data from an endothelial cell culture
model showed that Hantaan virus which causes HFRS
in Asia induces TLR 4, responsible for enhanced pro-
duction of TNF-a as well as IFN-b1a n dI L - 6[ 3 4 ] .I n
two clinical studies in Belgium and Brazil, polymorph-
isms in the TNF-a promoter were found associated with
am o r es e v e r ec o u r s eo fd i s e a s ei nP U U Vi n f e c t i o na n d
susceptibility to HPS, respectively [11,38]. A pauci-
symptomatic case of PUUV infection in a patient under
anti TNF-a treatment supports a crucial role of TNF-a
in hantavirus pathogenesis [39].
One of the main pro-inflammatory proteins beside
TNF-a is IL-6 which is also involved in induction of
acute inflammatory responses. Severity of disease in
HFRS is correlated with serum and urine levels of IL-6
[40,41]. Outinen et al. found that high IL-6 is associated
with disease severity and increased hospitalization time
of PUUV infected patients [33]. Associations of high
serum creatinine and low platelet counts with serum
levels of TNF-a and IL-6 in our patients support the role
of these cytokines in HFRS. Further, in fatal cases with
HPS, high numbers of cytokine-producing cells (IL-6,
TNF-a,I F N - g and IL-2 among others) were seen in the
lung and spleen tissues of HPS patients, indicating a role
for cytokines also in the target organ [10]. In our study
we could show a significant decrease of several main
inflammatory cytokines from early to late phase acute
disease and induction of an immunosuppressive mechan-
ism characterized by significant increase in TGF-b1
which is supposed to have a negative influence on lym-
phocyte activation [42]. In contrast to others we did not
see an increase in IL-10 during acute infection but only a
significant decrease of IL-10 from early to late phase
whereas increased TNF-b1 was seen in both early and
late phase versus healthy controls and additionally
showed a significant increase from early to late phase
samples [14,16,43]. These differences in the detection of
certain cytokines could be due to the varying sampling
time points after onset of disease or a mixture of patients
at early and late phase of acute disease in studies which
did not evaluate the time span from onset of first symp-
toms. Near-normal platelet numbers as well as only a
small increase from creatinine on admission to maximum
creatinine value indicated that - similar to most other
studies- we missed the very early phase of disease in our
cohort as well. Generally, due to the unspecific nature of
hantavirus symptoms, it is very difficult to evaluate the
very early cytokine response as patients are rarely seen
and diagnosed within the first days of infection [15].
In general, our findings support the induction of an
inhibitory effect from early to late course of disease
which limits early acute phase pro-inflammatory
r e s p o n s e .I n t e r e s t i n g l y ,t his immunoregulatory effect
seems to be optimized for virus persistence in the reser-
voir host characterized by asymptomatic infection: East-
erbrook et al. found regulatory T cells mediating Seoul
virus persistence in rats, possibly through elevated tran-
scription and synthesis of TGF-b1 and suppression of
TNF in the natural reservoir host [44]. In deer mice per-
sistently infected with Sin Nombre virus, T cells from
acutely infected mice synthesized a broad spectrum of
cytokines, including IFN-g, IL-4, IL-5, and TGF-b1, but
not TNF, lymphotoxin, or IL-17. However, in T cells
from persistently infected deer mice, only TGF-b1w a s
expressed by all cell lines, whereas some cell lines
expressed reduced levels of IFN-g or IL-5 [45].
Conclusions
The strong association of high TGF-b1 serum level with
low serum creatinine and high platelet counts in our
study suggests a protective immunoregulatory role of
high TGF-b1 mitigating clinical symptoms in the late
acute phase of hantavirus-infected patients. High TGF-
b1 serum levels inhibit pro-inflammatory cytokines and
Table 5 Correlation analysis of cytokine expression for
creatinine/cytokine ratio, platelet/cytokine ratio and CRP/
cytokine ratio.
parameter r p
Creatinine/IL-6 0.337 0.005
Creatinine/IL-8 0.316 0.009
Creatinine/TNF-a 0.560 <0.001
Creatinine/TGF-b1 -0.265 0.029
Platelets/IL-6 -0.396 0.001
Platelets/IL-10 -0.367 0.002
Platelets/TNF-a -0.391 0.003
Platelets/TGF-b1 0.421 <0.001
TGF-ß1/IL-8 - 0.26 0.030
TGF-ß1/IL-10 - 0.42 <0.0001
TGF-ß1/TNF-a - 0.30 0.017
CRP/IL-6 0.49 <0.0001
CRP/IL-8 0.34 0.004
CRP/TNF-a 0.46 0.0001
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inflammations and injuries of tissues and organs. Strong
associations of high TGF-b1 with low IL-8, IL-10 and
TNF-a serum levels during acute hantavirus infection
support this hypothesis. The strong association of high
TGF-b1 with high platelet counts point to platelets as
an additional source of increased serum TGF-b1d u r i n g
convalescence of the patients. Thus, the strong inflam-
matory immune response induces a counter regulation
with increased TGF-b1 originating from activated
immune cells such as T lymphocytes, monocytes and
macrophages. The counter regulation increased the
number of platelets to normal platelet counts and these
platelets might be activated and release additional TGF-
b1. The observation of decreased TGF-b1s e r u ml e v e l s
in patients with hantavirus pulmonary symptoms are in
line with our observation of high TGF-b1s e r u ml e v e l s
in asymptomatic convalescent patients [40].
Methods
Study population
Sixty-four hospitalised patients diagnosed with acute han-
tavirus infection at the University Hospital Heidelberg
were analyzed for clinical characteristics by hospital chart.
Hantavirus antibodies and cytokine levels were determined
in serum samples obtained during clinical routine. Early
phase samples of acute disease were from the first presen-
tation upon admission to the hospital, on average 6 days
after onset of symptoms. An additional late phase sample
was available for 21 of those patients, on average 12 days
after onset of symptoms. All samples were analysed for
cytokine expression levels. Thirty-nine healthy blood
donors (age 37.2±12.2 years) served as controls. Data on
nationwide demographic characteristics of hantavirus
cases were obtained from the central federal institution for
disease control Robert Koch Institute (SurvStat@RKI,
http://www3.rki.de/SurvStat, data status: 14.02.2011).
Detection of hantavirus antibodies
Sera were tested for IgG and IgM antibodies using the
recomLine hantavirus assay (Mikrogen, Munich, Ger-
many), coated with specific hantavirus nucleocapsid
antigens of Puumala virus, Hantaan virus and Seoul
virus. Patients were included in the study if both IgG
and IgM for Puumala were positive on admission or
during the course of disease.
Determination of serum cytokines
IL-2, IL-5, IL-6, IL-8, IL-10, IFN-g, TGF- b1 and TNF-a
were measured by ELISA (R&D Systems, Wiesbaden,
Germany) in 64 early and 21 late phase samples.
To exclude cytokine accumulation due to dysfunction
of renal excretion function in our analysis, in addition,
cytokine/creatinine ratios were calculated.
Statistical analysis
Mann-Whitney-U, Wilcoxon signed rank and Spearman
correlation coefficient test were applied using the Statis-
tical Package for the Social Sciences (SPSS, Chicago,
USA). Adjustment for multiple testing was done accord-
ing to the method of Bonferroni. P values of <0.05 after
adjustment were considered significant.
Ethical approval
This study was approved by the Ethics Committee of
the Faculty of Medicine, University Heidelberg. Written
consent was obtained from patients and healthy
controls.
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